Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 it is hereby informed that the Officials of Supriya Lifescience Limited (Company) had interacted with institutional investors/analysts on November 23 2022 via video conference.